newsfilter
← Latest News
GlobeNewswire·

BioAtla to Announce First Quarter 2025 Financial Results and Provide Business Highlights on May 6, 2025

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the